Understanding how protein quality control affects aging and related diseases
Protein quality control in age-related diseases
This study is exploring how the way our cells manage proteins might affect aging and diseases like Alzheimer's, focusing on a special protein called CHIP that helps keep everything running smoothly in our cells.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10809716 on NIH RePORTER |
What this research studies
This research investigates the role of protein quality control in age-related diseases, particularly focusing on Alzheimer's disease and other degenerative conditions. It examines how proteins fold and are degraded within cells, which is crucial for maintaining cellular health. The study specifically looks at a protein called CHIP, which is involved in both the proper folding and degradation of other proteins that are important for cellular function and response to stress. By understanding these mechanisms, the research aims to uncover how disruptions in protein quality control contribute to aging and related diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are experiencing symptoms of aging or have been diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients who are younger than 21 or do not have any age-related diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing or treating age-related diseases like Alzheimer's.
How similar studies have performed: Other research has shown promising results in understanding protein quality control mechanisms, suggesting that this approach could yield significant insights into age-related diseases.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Schisler, Jonathan C. — Univ of North Carolina Chapel Hill
- Study coordinator: Schisler, Jonathan C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.